| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 10 | 2024 | 526 | 2.330 |
Why?
|
| Cognitive Dysfunction | 21 | 2024 | 1020 | 2.190 |
Why?
|
| Alzheimer Disease | 23 | 2024 | 2062 | 2.020 |
Why?
|
| Brain | 17 | 2023 | 1643 | 1.340 |
Why?
|
| Models, Statistical | 3 | 2016 | 122 | 1.190 |
Why?
|
| Cognition Disorders | 11 | 2023 | 984 | 1.150 |
Why?
|
| Aged | 58 | 2024 | 8765 | 1.080 |
Why?
|
| Aging | 18 | 2023 | 1538 | 1.070 |
Why?
|
| Longitudinal Studies | 19 | 2023 | 1343 | 1.040 |
Why?
|
| Humans | 87 | 2024 | 26286 | 0.960 |
Why?
|
| Aged, 80 and over | 42 | 2024 | 4675 | 0.950 |
Why?
|
| Cognition | 15 | 2023 | 1291 | 0.890 |
Why?
|
| Software | 1 | 2023 | 65 | 0.880 |
Why?
|
| Radar | 1 | 2022 | 6 | 0.800 |
Why?
|
| Algorithms | 3 | 2023 | 366 | 0.780 |
Why?
|
| Female | 65 | 2023 | 14539 | 0.780 |
Why?
|
| Male | 64 | 2023 | 14162 | 0.780 |
Why?
|
| Literacy | 1 | 2021 | 16 | 0.720 |
Why?
|
| Music | 1 | 2021 | 19 | 0.720 |
Why?
|
| Death | 1 | 2021 | 47 | 0.720 |
Why?
|
| Educational Status | 2 | 2021 | 288 | 0.700 |
Why?
|
| Risk Factors | 23 | 2023 | 2265 | 0.680 |
Why?
|
| Depression | 6 | 2020 | 407 | 0.660 |
Why?
|
| Diabetes Mellitus | 6 | 2023 | 126 | 0.640 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 26 | 0.640 |
Why?
|
| Influenza, Human | 9 | 2015 | 40 | 0.630 |
Why?
|
| Orthomyxoviridae Infections | 7 | 2015 | 9 | 0.610 |
Why?
|
| Depressive Disorder | 1 | 2019 | 167 | 0.600 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 82 | 0.540 |
Why?
|
| Biostatistics | 1 | 2016 | 5 | 0.540 |
Why?
|
| Brazil | 5 | 2021 | 35 | 0.510 |
Why?
|
| Zoonoses | 8 | 2015 | 9 | 0.490 |
Why?
|
| Cohort Studies | 15 | 2022 | 1838 | 0.480 |
Why?
|
| Odds Ratio | 3 | 2018 | 265 | 0.450 |
Why?
|
| Blood Pressure | 3 | 2020 | 199 | 0.450 |
Why?
|
| Influenza A virus | 5 | 2012 | 15 | 0.440 |
Why?
|
| Neuropsychological Tests | 12 | 2023 | 1223 | 0.440 |
Why?
|
| Intracranial Aneurysm | 4 | 2018 | 41 | 0.440 |
Why?
|
| Body Mass Index | 4 | 2023 | 427 | 0.430 |
Why?
|
| Cerebrovascular Disorders | 3 | 2021 | 133 | 0.420 |
Why?
|
| Brain Infarction | 3 | 2020 | 74 | 0.400 |
Why?
|
| Seroepidemiologic Studies | 7 | 2010 | 19 | 0.400 |
Why?
|
| Swine Diseases | 5 | 2012 | 5 | 0.390 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 114 | 0.390 |
Why?
|
| Hospitalization | 3 | 2019 | 294 | 0.390 |
Why?
|
| Antibodies, Viral | 9 | 2015 | 53 | 0.390 |
Why?
|
| Memory, Episodic | 3 | 2023 | 115 | 0.390 |
Why?
|
| Occupational Exposure | 8 | 2015 | 17 | 0.390 |
Why?
|
| Insulin | 3 | 2021 | 76 | 0.380 |
Why?
|
| Neuropathology | 3 | 2022 | 83 | 0.360 |
Why?
|
| Family | 2 | 2021 | 93 | 0.340 |
Why?
|
| Amyloid beta-Peptides | 4 | 2023 | 319 | 0.340 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 254 | 0.330 |
Why?
|
| Stress, Psychological | 3 | 2021 | 212 | 0.320 |
Why?
|
| Prospective Studies | 9 | 2023 | 1668 | 0.320 |
Why?
|
| Autopsy | 8 | 2023 | 340 | 0.310 |
Why?
|
| Hippocampus | 4 | 2022 | 262 | 0.300 |
Why?
|
| Child, Preschool | 8 | 2022 | 593 | 0.300 |
Why?
|
| Disease Progression | 4 | 2021 | 687 | 0.300 |
Why?
|
| Swine | 8 | 2012 | 65 | 0.300 |
Why?
|
| Animals | 16 | 2022 | 3538 | 0.280 |
Why?
|
| Communicable Diseases | 1 | 2007 | 23 | 0.280 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2019 | 25 | 0.280 |
Why?
|
| Disease Outbreaks | 3 | 2013 | 78 | 0.280 |
Why?
|
| Cognitive Aging | 2 | 2018 | 79 | 0.260 |
Why?
|
| HIV Infections | 2 | 2021 | 460 | 0.260 |
Why?
|
| Adenoviruses, Human | 3 | 2009 | 4 | 0.250 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 110 | 0.250 |
Why?
|
| Adenovirus Infections, Human | 3 | 2009 | 3 | 0.240 |
Why?
|
| Middle Aged | 23 | 2021 | 8601 | 0.240 |
Why?
|
| Perception | 3 | 2021 | 74 | 0.240 |
Why?
|
| Intracranial Arteriosclerosis | 3 | 2021 | 53 | 0.240 |
Why?
|
| Arteriolosclerosis | 2 | 2023 | 78 | 0.240 |
Why?
|
| Cytomegalovirus Infections | 2 | 2015 | 35 | 0.230 |
Why?
|
| Nervous System Diseases | 2 | 2023 | 117 | 0.230 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2008 | 14 | 0.220 |
Why?
|
| Interviews as Topic | 2 | 2021 | 123 | 0.220 |
Why?
|
| Independent Living | 3 | 2021 | 306 | 0.220 |
Why?
|
| Signal Transduction | 3 | 2021 | 409 | 0.220 |
Why?
|
| Metformin | 1 | 2023 | 18 | 0.220 |
Why?
|
| Computer Simulation | 2 | 2016 | 196 | 0.210 |
Why?
|
| United States | 11 | 2024 | 1990 | 0.210 |
Why?
|
| Acculturation | 1 | 2023 | 36 | 0.210 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2023 | 12 | 0.210 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2023 | 28 | 0.210 |
Why?
|
| Risk Assessment | 3 | 2022 | 629 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2023 | 49 | 0.200 |
Why?
|
| Social Participation | 1 | 2022 | 11 | 0.200 |
Why?
|
| Age Factors | 7 | 2021 | 753 | 0.200 |
Why?
|
| Diet, Mediterranean | 1 | 2023 | 80 | 0.190 |
Why?
|
| Hemoglobins | 1 | 2022 | 75 | 0.190 |
Why?
|
| Ventriculostomy | 2 | 2012 | 5 | 0.190 |
Why?
|
| Cause of Death | 1 | 2021 | 57 | 0.190 |
Why?
|
| Lewy Bodies | 3 | 2019 | 193 | 0.190 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 853 | 0.190 |
Why?
|
| Mathematics | 1 | 2021 | 31 | 0.190 |
Why?
|
| Social Discrimination | 1 | 2021 | 7 | 0.180 |
Why?
|
| Neuroticism | 1 | 2021 | 32 | 0.180 |
Why?
|
| Writing | 1 | 2021 | 18 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2021 | 45 | 0.180 |
Why?
|
| Reading | 1 | 2021 | 40 | 0.180 |
Why?
|
| Cerebral Infarction | 2 | 2023 | 150 | 0.180 |
Why?
|
| Medicare | 4 | 2024 | 114 | 0.180 |
Why?
|
| Agriculture | 3 | 2010 | 3 | 0.180 |
Why?
|
| Influenza in Birds | 3 | 2011 | 3 | 0.170 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 1738 | 0.170 |
Why?
|
| Physical Fitness | 1 | 2020 | 57 | 0.170 |
Why?
|
| Hypertension | 2 | 2020 | 223 | 0.170 |
Why?
|
| Adipokines | 1 | 2019 | 7 | 0.170 |
Why?
|
| Linear Models | 2 | 2020 | 239 | 0.170 |
Why?
|
| Neurons | 1 | 2022 | 315 | 0.170 |
Why?
|
| Exercise | 2 | 2021 | 451 | 0.170 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 14 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 333 | 0.160 |
Why?
|
| Adult | 18 | 2018 | 7448 | 0.160 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 18 | 0.160 |
Why?
|
| Cerebral Arteries | 2 | 2016 | 24 | 0.160 |
Why?
|
| Motor Disorders | 1 | 2019 | 24 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 34 | 0.160 |
Why?
|
| Neurofibrillary Tangles | 2 | 2017 | 191 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 2 | 2015 | 61 | 0.160 |
Why?
|
| Aneurysm, Ruptured | 3 | 2018 | 16 | 0.160 |
Why?
|
| tau Proteins | 1 | 2020 | 225 | 0.160 |
Why?
|
| Memory Disorders | 1 | 2020 | 164 | 0.160 |
Why?
|
| Animal Husbandry | 2 | 2008 | 8 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 99 | 0.150 |
Why?
|
| Logistic Models | 2 | 2016 | 365 | 0.150 |
Why?
|
| Proteomics | 1 | 2019 | 90 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2019 | 134 | 0.150 |
Why?
|
| Rural Population | 3 | 2013 | 23 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 93 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2021 | 3367 | 0.150 |
Why?
|
| Antibodies, Bacterial | 2 | 2008 | 18 | 0.150 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 143 | 0.150 |
Why?
|
| Learning | 1 | 2018 | 63 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 2 | 2023 | 108 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2017 | 68 | 0.140 |
Why?
|
| Agricultural Workers' Diseases | 2 | 2007 | 2 | 0.140 |
Why?
|
| Infant | 6 | 2023 | 520 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 191 | 0.140 |
Why?
|
| Young Adult | 9 | 2015 | 1886 | 0.140 |
Why?
|
| Paramyxoviridae Infections | 2 | 2006 | 2 | 0.140 |
Why?
|
| Metapneumovirus | 2 | 2006 | 2 | 0.140 |
Why?
|
| Likelihood Functions | 1 | 2016 | 24 | 0.130 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 2 | 2013 | 2 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 2016 | 42 | 0.130 |
Why?
|
| Hemagglutination Inhibition Tests | 3 | 2015 | 4 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2017 | 419 | 0.130 |
Why?
|
| Horse Diseases | 1 | 2015 | 3 | 0.120 |
Why?
|
| Serologic Tests | 1 | 2015 | 9 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 97 | 0.120 |
Why?
|
| Iowa | 6 | 2015 | 11 | 0.120 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 204 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 7 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 7 | 0.110 |
Why?
|
| Pyridines | 1 | 2014 | 36 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2014 | 78 | 0.110 |
Why?
|
| Adolescent | 8 | 2015 | 2080 | 0.110 |
Why?
|
| Neutralization Tests | 2 | 2015 | 9 | 0.110 |
Why?
|
| Child | 7 | 2012 | 1236 | 0.100 |
Why?
|
| DNA, Viral | 2 | 2009 | 36 | 0.100 |
Why?
|
| Sclerosis | 3 | 2019 | 67 | 0.100 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cerebellar Diseases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Third Ventricle | 1 | 2012 | 2 | 0.100 |
Why?
|
| Asymptomatic Infections | 1 | 2011 | 1 | 0.100 |
Why?
|
| Poultry Diseases | 1 | 2011 | 2 | 0.100 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 305 | 0.090 |
Why?
|
| Chicago | 3 | 2020 | 843 | 0.090 |
Why?
|
| Aspirin | 1 | 2011 | 78 | 0.090 |
Why?
|
| Decompression, Surgical | 1 | 2012 | 129 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 21 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 130 | 0.090 |
Why?
|
| Stents | 1 | 2010 | 76 | 0.090 |
Why?
|
| Self Report | 2 | 2021 | 204 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 303 | 0.080 |
Why?
|
| Adenoviridae Infections | 1 | 2009 | 2 | 0.080 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2021 | 69 | 0.080 |
Why?
|
| Streptococcus suis | 1 | 2008 | 1 | 0.080 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 8 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 1157 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2022 | 164 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2007 | 15 | 0.070 |
Why?
|
| Veterinarians | 1 | 2007 | 1 | 0.070 |
Why?
|
| Influenza A Virus, H5N2 Subtype | 1 | 2007 | 1 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 22 | 0.070 |
Why?
|
| Ehrlichiosis | 1 | 2006 | 1 | 0.070 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2006 | 1 | 0.070 |
Why?
|
| Deer | 1 | 2006 | 2 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 150 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 115 | 0.070 |
Why?
|
| Poultry | 3 | 2011 | 3 | 0.060 |
Why?
|
| Prevalence | 3 | 2014 | 437 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 566 | 0.050 |
Why?
|
| 5-Methylcytosine | 1 | 2023 | 4 | 0.050 |
Why?
|
| Comorbidity | 2 | 2014 | 475 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 117 | 0.050 |
Why?
|
| Horses | 2 | 2015 | 8 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 34 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2023 | 122 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2021 | 56 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 460 | 0.050 |
Why?
|
| Causality | 1 | 2020 | 52 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 485 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 91 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2009 | 5 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2014 | 3391 | 0.040 |
Why?
|
| Leptin | 1 | 2019 | 19 | 0.040 |
Why?
|
| Sex Factors | 2 | 2011 | 450 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2019 | 31 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 138 | 0.040 |
Why?
|
| Smoking | 1 | 2020 | 170 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 561 | 0.040 |
Why?
|
| Birds | 2 | 2008 | 5 | 0.040 |
Why?
|
| Social Isolation | 1 | 2018 | 22 | 0.040 |
Why?
|
| Mice | 1 | 2022 | 1290 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 51 | 0.040 |
Why?
|
| Genotype | 2 | 2009 | 335 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2009 | 593 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2017 | 110 | 0.030 |
Why?
|
| Peru | 2 | 2007 | 3 | 0.030 |
Why?
|
| Religious Personnel | 1 | 2016 | 11 | 0.030 |
Why?
|
| PubMed | 1 | 2016 | 10 | 0.030 |
Why?
|
| Arterioles | 1 | 2016 | 9 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 51 | 0.030 |
Why?
|
| Phylogeny | 2 | 2006 | 46 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 40 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 556 | 0.030 |
Why?
|
| Brain Stem | 1 | 2016 | 19 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 67 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2015 | 62 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 621 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 21 | 0.030 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2014 | 7 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 2014 | 7 | 0.030 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2014 | 7 | 0.030 |
Why?
|
| Reaction Time | 1 | 2015 | 109 | 0.030 |
Why?
|
| Autoantigens | 1 | 2014 | 23 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2016 | 209 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 105 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 94 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 48 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 38 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 49 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 84 | 0.030 |
Why?
|
| Memory | 1 | 2015 | 299 | 0.030 |
Why?
|
| Cambodia | 1 | 2013 | 19 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 400 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2014 | 171 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 9 | 0.030 |
Why?
|
| Craniotomy | 1 | 2012 | 21 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 2012 | 2 | 0.030 |
Why?
|
| Central Nervous System Infections | 1 | 2012 | 3 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2012 | 18 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2012 | 112 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 616 | 0.020 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 1 | 0.020 |
Why?
|
| Thailand | 1 | 2011 | 10 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2012 | 78 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 235 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 162 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 252 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 149 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2010 | 6 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 312 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2010 | 31 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 46 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 39 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1391 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2012 | 290 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 199 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2009 | 7 | 0.020 |
Why?
|
| Connecticut | 1 | 2009 | 6 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 6 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 4 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 25 | 0.020 |
Why?
|
| Capsid Proteins | 1 | 2009 | 21 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 106 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2009 | 28 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 716 | 0.020 |
Why?
|
| Serotyping | 1 | 2008 | 10 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2008 | 29 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2008 | 18 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2008 | 10 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2008 | 31 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 39 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 23 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 81 | 0.020 |
Why?
|
| Midwestern United States | 1 | 2008 | 62 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2007 | 5 | 0.020 |
Why?
|
| Carrier State | 1 | 2008 | 48 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 1074 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 91 | 0.020 |
Why?
|
| Chickens | 1 | 2007 | 32 | 0.020 |
Why?
|
| Hemagglutination Tests | 1 | 2006 | 3 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 723 | 0.020 |
Why?
|
| Arachnid Vectors | 1 | 2006 | 1 | 0.020 |
Why?
|
| Ixodes | 1 | 2006 | 1 | 0.020 |
Why?
|
| Animals, Wild | 1 | 2006 | 2 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2006 | 6 | 0.020 |
Why?
|
| Disease Reservoirs | 1 | 2006 | 8 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2006 | 11 | 0.020 |
Why?
|
| Pharynx | 1 | 2006 | 12 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2006 | 78 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 679 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 163 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2006 | 40 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2006 | 47 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 135 | 0.020 |
Why?
|
| Hospitals | 1 | 2006 | 150 | 0.020 |
Why?
|
| Cell Line | 1 | 2006 | 252 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2006 | 101 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 306 | 0.010 |
Why?
|